Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

Eur Heart J. 2019 Jan 7;40(2):216-217. doi: 10.1093/eurheartj/ehy675.

Felice Gragnano¹, Paolo Calabrò^{2

3}, Marco Valgimigli¹

¹ Department of Cardiology, Bern University Hospital, University of Bern, Freiburgstrasse 8, Bern, Switzerland.
² Division of Clinical Cardiology, A.O.R.N. Sant'Anna e San Sebastiano, F. Palasciano, Caserta, Italy.
³ Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", P.zza L. Miraglia 2, Naples, Italy.

No abstract available

Publication types